Total Payments
$3,010
2024 Payments
$666.48
Companies
28
Transactions
144
Medicare Patients
5,667
Medicare Billing
$464,733
Payment Breakdown by Category
Food & Beverage$2,899 (96.3%)
Education$110.63 (3.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,899 | 142 | 96.3% |
| Education | $110.63 | 2 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $729.90 | 37 | $0 (2024) |
| DENTSPLY IH AB | $425.39 | 17 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $325.58 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $240.03 | 13 | $0 (2024) |
| Medtronic, Inc. | $146.77 | 2 | $0 (2024) |
| 180 Medical, Inc. | $125.27 | 4 | $0 (2022) |
| ABBVIE INC. | $115.09 | 6 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $97.26 | 6 | $0 (2024) |
| Teleflex LLC | $84.42 | 3 | $0 (2023) |
| UROGEN PHARMA, INC. | $82.36 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $666.48 | 25 | DENTSPLY IH AB ($250.03) |
| 2023 | $689.55 | 35 | Sumitomo Pharma America, Inc. ($224.68) |
| 2022 | $272.10 | 12 | Astellas Pharma US Inc ($81.63) |
| 2021 | $190.20 | 5 | Astellas Pharma US Inc ($99.99) |
| 2020 | $78.01 | 5 | Astellas Pharma US Inc ($46.80) |
| 2019 | $480.29 | 27 | Astellas Pharma US Inc ($123.38) |
| 2018 | $410.00 | 22 | Astellas Pharma US Inc ($169.64) |
| 2017 | $223.26 | 13 | Astellas Pharma US Inc ($104.71) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $35.32 | General |
| Category: Medical Urology | ||||||
| 12/03/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $127.14 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/22/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Medical Urology | ||||||
| 11/05/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Medical Urology | ||||||
| 09/11/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $35.28 | General |
| Category: Medical Urology | ||||||
| 08/08/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Medical Urology | ||||||
| 07/02/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Medical Urology | ||||||
| 06/11/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/22/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: Medical Urology | ||||||
| 04/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Oncology | ||||||
| 04/12/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: Medical Urology | ||||||
| 04/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: HORMONE THERAPY | ||||||
| 03/28/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Medical Urology | ||||||
| 03/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ONCOLOGY | ||||||
| 03/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: UROLOGY | ||||||
| 03/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: UROLOGY | ||||||
| 02/28/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: UROTHELIAL CANCER | ||||||
| 02/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: UROLOGY | ||||||
| 01/26/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Medical Urology | ||||||
| 01/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: UROLOGY | ||||||
| 01/09/2024 | Mission Pharmacal Company | URIBEL TABS (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: ANALGESIC, ANTISPASMODIC & ANTISEPTIC (URINARY) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,150 | 1,858 | $312,740 | $84,966 |
| 2022 | 17 | 1,392 | 2,147 | $473,825 | $116,287 |
| 2021 | 18 | 1,495 | 2,142 | $571,420 | $134,506 |
| 2020 | 19 | 1,630 | 2,409 | $594,070 | $128,973 |
Total Patients
5,667
Total Services
8,556
Medicare Billing
$464,733
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 429 | 707 | $134,330 | $44,500 | 33.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 102 | $77,010 | $13,644 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 105 | $28,875 | $10,669 | 37.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 34 | 45 | $31,500 | $8,668 | 27.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 447 | 741 | $11,115 | $2,509 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $6,050 | $1,539 | 25.4% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 12 | 12 | $12,000 | $1,294 | 10.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 18 | $2,340 | $752.32 | 32.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 58 | 71 | $4,260 | $573.93 | 13.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 16 | $1,840 | $437.96 | 23.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 18 | 19 | $3,420 | $377.53 | 11.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 492 | 779 | $152,070 | $52,335 | 34.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 15 | 144 | $159,480 | $20,702 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 152 | $44,125 | $14,374 | 32.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 48 | 64 | $39,600 | $13,154 | 33.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $10,425 | $2,547 | 24.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 16 | 52 | $12,060 | $2,522 | 20.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 457 | 680 | $13,260 | $2,312 | 17.4% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2022 | 15 | 15 | $14,220 | $1,434 | 10.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 15 | $3,950 | $1,277 | 32.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 21 | $4,005 | $1,244 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $5,750 | $1,097 | 19.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 21 | $2,665 | $867.49 | 32.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 30 | 36 | $4,140 | $715.07 | 17.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 15 | 25 | $3,055 | $661.58 | 21.7% |
About Dr. Milton Coll, MD
Dr. Milton Coll, MD is a Urology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487657086.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Milton Coll, MD has received a total of $3,010 in payments from pharmaceutical and medical device companies, with $666.48 received in 2024. These payments were reported across 144 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,899).
As a Medicare-enrolled provider, Coll has provided services to 5,667 Medicare beneficiaries, totaling 8,556 services with total Medicare billing of $464,733. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Philadelphia, PA
- Active Since 05/27/2005
- Last Updated 11/28/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1487657086
Products in Payments
- XTANDI (Drug) $319.40
- GEMTESA (Drug) $277.42
- LOFRIC (Device) $250.03
- LoFric (Device) $241.68
- Xtandi (Drug) $202.78
- INTERSTIM (Device) $146.77
- ORGOVYX (Drug) $96.15
- MYRBETRIQ (Drug) $89.96
- Myrbetriq (Drug) $87.31
- Erleada (Drug) $86.00
- UROLIFT (Device) $84.42
- JELMYTO (Drug) $82.36
- PROVENGE (Drug) $80.44
- ERLEADA (Drug) $78.41
- ZYTIGA (Drug) $75.62
- FIRMAGON (Drug) $61.92
- Rezum (Device) $57.16
- Cysview (Drug) $39.45
- VESICARE (Drug) $37.53
- Noctiva (Drug) $36.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Philadelphia
Dr. Daniel Eun, M.d, M.D
Urology — Payments: $382,660
Urology $382,660
Paul Chung, M.d, M.D
Urology — Payments: $251,745
Urology $251,745
Dr. Leonard Gomella, M.d, M.D
Urology — Payments: $248,176
Urology $248,176
Dr. Jay Simhan, M.d, M.D
Urology — Payments: $190,984
Urology $190,984
Robert Uzzo, Md02041967, MD02041967
Urology — Payments: $188,129
Urology $188,129
Dr. Edouard Trabulsi, M.d, M.D
Urology — Payments: $177,442
Urology $177,442